DRAQ7 in Cell Health Assays

8 Oct 2018

One of the biggest costs in drug discovery and development has been failures of drug candidates after launch, due to unexpected or idiosyncratic toxicity. In this application note, learn how the DNA-binding viability probe, DRAQ7, is used in image-based and FC-based cell health assays to determine dead or dying cells.

Links

Tags